Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Partnership Announced by ingenious targeting laboratory and Shanghai Model Organisms Center to Distribute Catalog Humanized Mouse Models

ingenious and SMOC sign agreement to produce and distribute catalog mouse models


News provided by

ingenious targeting laboratory

Jun 03, 2021, 11:20 ET

Share this article

Share toX

Share this article

Share toX


RONKONKOMA, N.Y. and SHANGHAI, June 3, 2021 /PRNewswire-PRWeb/ -- ingenious targeting laboratory, a leading provider of custom animal models for in vivo studies, and Shanghai Model Organisms Center, "SMOC," a major supplier of laboratory rodents and services, announced a partnership that grants rights for ingenious targeting laboratory to distribute SMOC's validated off-the-shelf mouse models in North America and Europe. This follows upon an agreement which grants SMOC the right to market ingenious' custom large humanization mouse model services in China. The companies' strict adherence to common practices for rodent health and genetic monitoring will ensure minimal variation between the animals produced in China and North America, for researchers worldwide.

For over twenty years, SMOC has produced genetically modified mouse models for researchers around the globe. The company has generated over 8000 mouse strains, including over 3000 study-ready models. Most notably, their humanized PD-1/PD-L1, TIGIT, and SIRPA/CD47 strains are highly demanded by industrial clients for antibody drug efficacy studies. These strains will be sold by ingenious targeting laboratory, as well as many other immune checkpoint humanized mouse strains.

Clients can now enjoy the convenience of purchasing SMOC’s research-ready catalog models through ingenious as a trusted vendor.

Post this

In addition, SMOC is known as a "one-stop shop," as their service offerings include custom mouse models, catalog mouse models, breeding services, and phenotypic analysis. Through this collaboration, customers in China can purchase advanced custom models created using ingenious' exclusive TruHumanization™ gene replacement technology. Furthermore, ingenious targeting laboratory will expand its current services beyond custom mouse, rat, and rabbit generation, breeding, and genotyping. Clients can now enjoy the convenience of purchasing SMOC's research-ready catalog models through ingenious as a trusted vendor.

"The demand for our off-the-shelf mouse models has increased steadily in China over the last few years. This partnership with ingenious will only expand the use of these lines that we have generated in China for North American and European researchers at both the academic and pharma/biotech sectors. We see the demand for many of these lines worldwide and ingenious targeting laboratory is highly regarded for their custom generation, breeding and delivery of high quality models," said Mingjun Wang, President of SMOC.

"We are excited that ingenious will be able to distribute the validated targeting lines that SMOC has produced. By introducing SMOC's unique systems of production and quality control, we are confident that we will offer high quality animals," said Paul Sheiffele, President of ingenious targeting laboratory. "Extensive access of these off-the-shelf models will speed the use of mouse models for scientists in their studies."

To learn more about SMOC's catalog humanized mouse models distributed by ingenious, visit genetargeting.com for more information and to place an order.

About Shanghai Model Organisms Center, Inc. (SMOC)

Founded in 2000, Shanghai Model Organisms Center, Inc. (SMOC) is a leading company in China, providing high-quality animal models and related services to global researchers.

SMOC strives to be the best-in-class resource center for biomedical researchers and industry partners, with its highly efficient and reliable technology platform. SMOC has been dedicated to developing a comprehensive product portfolio, comprised of both highly customized solutions including GEM models and off-the-shelf products. SMOC owns a rapidly expanding repository of Research-Ready models, many of which are designed for cutting-edge biomedical research such as immuno-oncology studies and therapeutic antibody development.

The supply of animal models to customers is assured by state-of-art animal facilities. Currently SMOC operates multiple AAALAC accredited breeding facilities in Shanghai. Also, in the past decade, SMOC has established a global service network powered by a superior technical platform, a talented scientific team and a group of dedicated technical support. We proudly work together with researchers from world-renowned academic institutes across the US, EU and APAC, as well as top pharmaceutical companies both domestically and internationally.

About ingenious targeting laboratory, Inc.

Since 1998, ingenious targeting laboratory is a leading global provider in generating custom genetically modified mouse, rat, and rabbit models. We stand as one of the very first mouse gene targeting companies. Each of our custom models is tailored to the exact needs of our clients for study in the fields of immunology, neuroscience, cancer, and more. We use classic and cutting-edge technologies, such as CRISPR and ES cells, for advanced animal model production. In addition, our models have been published in hundreds of journals, including Cell, Nature, and Science. This makes us one of the most validated and trusted production companies in the industry. When our clients choose to work with us, they can expect full confidentiality and to retain full intellectual property rights to their custom animal model projects.

Media Contact

Alexa Bauman, ingenious targeting laboratory, +1 (631) 468-8530 Ext: 117, [email protected]

Twitter, Facebook

SOURCE ingenious targeting laboratory

Related Links

https://www.genetargeting.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.